Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results

2 years ago

Revenues increased 7% in Q4 2022 compared to Q4 2021Net loss per share improved quarter over quarter and year over…

Psyched Wellness Announces July 19th, 2022 As the Official Date To Commence Pre-Orders for Calm

3 years ago

The announcement comes on the company's second anniversary, marking its growth and successToronto, Ontario--(Newsfile Corp. - July 13, 2022) -…

CENTR Brands Announces Strong Fourth Quarter Growth

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - July 13, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),…

NutriSense Raises $25 Million to Drive Continued Growth

3 years ago

Digital Health Company to Use New Investment Funds to Grow Team and Expand Reach CHICAGO--(BUSINESS WIRE)--#glucose--NutriSense, the metabolic health technology…

Lazurite™ Named a 2022 Top 10 Surgical Solutions Provider by MedTech Outlook Magazine

3 years ago

CLEVELAND--(BUSINESS WIRE)--#MedTechInnovator--Medical device and technology company Lazurite has been recognized by MedTech Outlook magazine as a 2022 Top 10 Surgical…

CEVEC’s License Partner RZNOMICS Inc. Receives Approval to Initiate Clinical Development of CAP(R) Ad Technology-Produced Gene Therapy Vector in Liver Cancer Patients

3 years ago

RZNOMICS uses CEVEC's CAP® Ad viral vector manufacturing technology for manufacturing gene therapy vectors targeting various cancer indicationsSouth Korean Ministry…

Three Poko Products Shortlisted As Finalists For The Free Form Skincare Awards 2022

3 years ago

Finalists Include Brightening Rosewater Toner, Soothing Serum and Hempsoriasis BalmAwards Will Be Announced July 19LONDON, UK and DUBLIN, IRELAND /…

Moderna to Report First Quarter Financial Results on Wednesday, August 3, 2022

3 years ago

CAMBRIDGE, MA / ACCESSWIRE / July 13, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

COSELA® (Trilaciclib Hydrochloride for Injection) Now Approved in China to Decrease the Incidence of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

3 years ago

RESEARCH TRIANGLE PARK, N.C., July 13, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today…

Inovalon Launches Race & Ethnicity Data Enrichment Offering as Part of its QSI-XL® Software Solution

3 years ago

New Offering Helps Health Plans Dramatically Improve Data Completeness to Better Identify Care Disparities Across Member Populations and Supports New…